1. Pink Sheet
  3. >>Clinical Trials

Industry Urged To Respond To EU Expectations On Using Animal Testing Alternatives

 
• By Eliza Slawther

The chair of a European Medicines Agency working group on reducing animal testing said that companies can provide “thoughts and suggestions” in relation to a review of its scientific guidelines on regulatory testing requirements and new approach methodologies.

EU regulators are updating scientific guidelines around alternatives to animal testing (Shutterstock)
Key Takeaways
  • A European Medicines Agency reflection paper lists the current expectations for using alternatives to animal testing in drug development and includes newly identified opportunities for reducing animal tests.

Companies are being reminded to share any views they might have about the European Medicines Agency’s

More from Clinical Trials

More from Pathways & Standards